← Leaderboards
Daniel Tamez
Heartware, Inc.
$9,073,712
Attributed
$9,073,712
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.6M · FY2011–25$5M$3.8M$2.5M$1.3M$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,073,712 · 3
By mechanism
R44$8,687,899 · 2
R43$385,813 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Ventricular Assist Device”
- Annetine A Gelijns · Columbia University Health Sciences$20,922,853
- Kiyotaka Fukamachi · Cleveland Clinic Lerner Col/Med-Cwru$15,533,064
- Danny Bluestein · State University New York Stony Brook$12,951,842
- Gerson Rosenberg · Pennsylvania State Univ Hershey Med Ctr$11,711,500
- Mark D Rodefeld · Indiana Univ-Purdue Univ At Indianapolis$10,850,067
- Bartley Perry Griffith · University Of Pittsburgh At Pittsburgh$10,766,949
Research focus
Ventricular Assist DevicePumpPre-ClinicalVentricularMiniaturizeHousingCardiovascular SystemPositioning AttributeHeart FailureQuality Of LifeLeftImplantVerification And ValidationChronicAcuteCardiopulmonary BypassDesignHemolysisDevicesEngineeringCannulasLiquid SubstanceMarketingAdult
Grant awards (5)
Development of the Inspired Therapeutics NeoMate Mechanical Circulatory Support System for Neonates and Infants$2,632,311
R44 · FY2025 · HL · contact PI
Development of the Inspired Therapeutics NeoMate Mechanical Circulatory Support System for Neonates and Infants$2,435,370
R44 · FY2023 · HL · contact PI
Development of transapical MVAD for heart failure therapy$1,891,204
R44 · FY2014 · HL · contact PI
Development of transapical MVAD for heart failure therapy$1,729,014
R44 · FY2013 · HL · contact PI
Feasibility Testing of Miniaturized Ventricular Assist Device (MVAD)$385,813
R43 · FY2011 · HL · contact PI